Sabby Management 13F annual report
Sabby Management is an investment fund managing more than $7.53 billion ran by Robert Grundstein. There are currently 27 companies in Mr. Grundstein’s portfolio. The largest investments include Vivani Medical Inc and Core Scientific, together worth $3.44 billion.
$7.53 billion Assets Under Management (AUM)
As of 7th August 2024, Sabby Management’s top holding is 2,126,176 shares of Vivani Medical Inc currently worth over $2.68 billion and making up 35.6% of the portfolio value.
Relative to the number of outstanding shares of Vivani Medical Inc, Sabby Management owns less than approximately 0.1% of the company.
In addition, the fund holds 168,974 shares of Core Scientific worth $762 million.
The third-largest holding is Redhill Biopharma worth $497 million and the next is Greenwave Technology worth $406 million, with 229,472 shares owned.
Currently, Sabby Management's portfolio is worth at least $7.53 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Sabby Management
The Sabby Management office and employees reside in Miami Beach, Florida. According to the last 13-F report filed with the SEC, Robert Grundstein serves as the Chief Operating Officer at Sabby Management.
Recent trades
In the most recent 13F filing, Sabby Management revealed that it had opened a new position in
Core Scientific and bought 168,974 shares worth $762 million.
The investment fund also strengthened its position in BioVie by buying
43,920 additional shares.
This makes their stake in BioVie total 733,055 shares worth $294 million.
BioVie dropped 93.6% in the past year.
On the other hand, there are companies that Sabby Management is getting rid of from its portfolio.
Sabby Management closed its position in Tonix Pharmaceuticals Hldg on 14th August 2024.
It sold the previously owned 4,895,962 shares for $911 million.
Robert Grundstein also disclosed a decreased stake in Vivani Medical Inc by 0.2%.
This leaves the value of the investment at $2.68 billion and 2,126,176 shares.
One of the smallest hedge funds
The two most similar investment funds to Sabby Management are Hermes Investment Management Ltd and Capital Guardian Trust Co. They manage $7.52 billion and $7.42 billion respectively.
Robert Grundstein investment strategy
Sabby Management’s portfolio is diversified across 5 sectors.
Currently, their heaviest sector is Health Care — making up 51.6% of
the total portfolio value.
The fund focuses on investments in the United States as
22.2% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
30% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $101 million.
The complete list of Sabby Management trades based on 13F SEC filings
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Vivani Medical Inc |
20.46%
2,126,176
|
$2,678,982,000 | 35.58% |
| Tonix Pharmaceuticals Hldg |
Closed
4,895,962
|
$910,649,000 | |
| Core Scientific |
Opened
168,974
|
$762,073,000 | 10.12% |
| Global Mofy Metaverse Ltd |
Closed
641,078
|
$527,607,000 | |
| Redhill Biopharma Ltd. |
42.17%
1,341,189
|
$497,179,000 | 6.60% |
| Recon Technology Ltd |
Closed
2,840,592
|
$420,408,000 | |
| Greenwave Technology |
Opened
229,472
|
$406,165,000 | 5.39% |
| Eltek Ltd |
64.10%
40,565
|
$395,509,000 | 5.25% |
| Applied Uv Inc |
Closed
217,084
|
$323,455,000 | |
| Ishares Tr |
Opened
1,500
|
$304,335,000 | 4.04% |
| Reviva Pharmaceutcls Hldgs Inc |
Opened
236,997
|
$303,356,000 | 4.03% |
| BioVie Inc. |
6.37%
733,055
|
$293,589,000 | 3.90% |
| Lipella Pharmaceuticals Inc |
116.19%
540,250
|
$243,113,000 | 3.23% |
| Biorestorative Therapies Inc |
Closed
168,544
|
$232,591,000 | |
| Pineapple Energy Inc |
Closed
3,400,134
|
$231,209,000 | |
| Transcode Therapeutics Inc |
Closed
334,823
|
$228,684,000 | |
| Sonnet Biotherapeutics Hldng Inc |
Opened
238,395
|
$223,495,000 | 2.97% |
| Glucotrack Inc |
Closed
614,636
|
$203,506,000 | |
| Sidus Space Inc |
No change
83,100
|
$194,454,000 | 2.58% |
| Ensysce Biosciences Inc |
36.35%
314,353
|
$159,220,000 | 2.11% |
| Aptevo Therapeutics Inc |
Opened
501,499
|
$153,459,000 | 2.04% |
| Bluejay Diagnostics Inc |
Closed
187,293
|
$150,359,000 | |
| Gevo Inc |
28.57%
250,000
|
$139,300,000 | 1.85% |
| Neximmune Inc |
16.62%
49,904
|
$137,730,000 | 1.83% |
| Scinai Immunotherapeutics Ltd |
Closed
253,135
|
$131,377,000 | |
| Avenue Therapeutics Inc |
Opened
37,394
|
$130,879,000 | 1.74% |
| Bynd Cannasoft Enterprises Inc |
Closed
92,420
|
$129,388,000 | |
| Processa Pharmaceuticals Inc |
Closed
48,601
|
$114,941,000 | |
| Effector Therapeutics |
Opened
352,084
|
$102,140,000 | 1.36% |
| Smart For Life Inc |
Opened
34,504
|
$102,132,000 | 1.36% |
| Avenue Therapeutics Inc |
Closed
670,926
|
$98,962,000 | |
| Briacell Therapeutics Corp |
Closed
34,222
|
$97,875,000 | |
| Akari Therapeutics Plc |
Closed
48,491
|
$90,436,000 | |
| Arcadia Biosciences Inc |
Closed
40,300
|
$89,063,000 | |
| Azitra Inc |
Closed
425,257
|
$87,390,000 | |
| China Natural Resources Inc |
75.55%
104,931
|
$82,161,000 | 1.09% |
| InMed Pharmaceuticals Inc. |
15.06%
307,236
|
$81,571,000 | 1.08% |
| iBio Inc |
Closed
14,000
|
$56,840,000 | |
| Biondvax Pharmaceuticals Ltd |
Opened
17,828
|
$49,562,000 | 0.66% |
| Core Scientific Inc |
Closed
14,497
|
$34,793,000 | |
| Applied Dna Sciences Inc |
Opened
70,463
|
$28,777,000 | 0.38% |
| Invo Bioscience Inc |
Closed
18,624
|
$21,045,000 | |
| 60 Degrees |
3.63%
295,589
|
$20,721,000 | 0.28% |
| SuperCom Ltd |
Closed
121,781
|
$20,216,000 | |
| Spire Global Inc |
Closed
1,518
|
$18,216,000 | |
| Wearable Devices Ltd |
38.93%
223,089
|
$13,318,000 | 0.18% |
| Amplitech Group Inc |
12.22%
332,716
|
$12,843,000 | 0.17% |
| Sunshine Biopharma Inc |
Opened
20,000
|
$8,350,000 | 0.11% |
| Tuanche Ltd |
Closed
4,179
|
$6,436,000 | |
| Cn Energy Group Inc |
Closed
5,000
|
$5,300,000 | |
| Innovative Eyewear Inc |
Closed
103,798
|
$5,242,000 | |
| Cingulate Inc |
2.18%
458,522
|
$4,952,000 | 0.07% |
| Jeffs Brands Ltd |
Closed
76,646
|
$4,476,000 | |
| SenesTech Inc |
Closed
6,260
|
$4,272,000 | |
| Greenwave Technology |
Closed
6,996
|
$847,000 | |
| No transactions found | |||
| Showing first 500 out of 55 holdings | |||
Hedge funds similar to Sabby Management
- Warburg Pincus & Co
- Fiat Wealth Management
- Penserra Capital Management
- Mitsubishi Ufj Morgan Stanley Securities Co
- Wealthnavi
- Wolfswood
- Covalent Partners
- Hermes Investment Management Ltd
- Capital Guardian Trust Co
- Fiduciary Trust Company International
- Ako Capital LL.P.
- Macellum Advisors, L.P.
- Rbc Capital Markets (1)
- Municipal Employees' Retirement System Of Michigan